New 3D heart imaging could sharpen ablation precision

NCT ID NCT07686328

First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time

Summary

This study tests a new imaging and guidance system called VERAFEYE that creates a 3D model of the heart to help doctors navigate during catheter ablation for atrial fibrillation. About 50 adults with paroxysmal or persistent atrial fibrillation will have their standard ablation procedure guided by this system. The goal is to see if the system helps complete the planned heart tissue lesions accurately and efficiently.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
VERAFEYE Imaging and Guidance System
What this could lead to
If successful, this imaging system could make catheter ablation for atrial fibrillation more precise and efficient, potentially improving outcomes.
What could go wrong
This is an early feasibility study with only 50 participants, so results may not generalize. The system may not improve navigation or could introduce unforeseen complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PAROXYSMAL ATRIAL FIBRILLATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.